Skip to content

Author

Lu-Na Zhao

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Efficacy and safety of immune checkpoint inhibitors combined with chemotherapy versus bevacizumab combined with chemotherapy in first-line treatment of driver gene-negative advanced non-squamous non-small cell lung cancer: a single-center retrospective study

For patients with driver gene-negative advanced non-squamous NSCLC, ICIs combined with chemotherapy are superior to bevacizumab combined with chemotherapy in terms of short-term efficacy and progression-free survival, with manageable but distinct adverse event profiles.

Wenqi Mo, Yin-zhen Li, Lu-Na Zhao et al. · 0 citations
Open access Aug 2026

Demographic time bomb in COPD (1990–2050)

This study provides the first comprehensive analysis of COPD epidemiology from 1990 to 2021 using Global Burden of Disease 2021 data, integrating multimodel projections to 2050 and risk factor attribution across SDI quintiles.

Dong Liu, Lu-Na Zhao, Lin Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.